Futura Medical Share Discussion Threads

[lbo] 16/12/2022 17:36

ROFLMAO

Thanks Petroc for highlighting that MED3000 will have even higher discontinuation rates then oral PDE5I.

As you confirmed men discontinue oral PDE5I because of lack of efficacy. So you are admitting I was right as even more more will discontinue MED3000 because it was proven to lack even more efficacy in FM71 then the lowest possible dose of Tadalafil.

‘Tadalafil was overall more effective then the placebo Med3000’



‘ lack of efficacy represented the most important reasons for PDE5i discontinuation’

[petroc] 16/12/2022 16:41

Quick description of LiarBO and his lying, scheming, dishonest stock bashing ways -

Stock bashing has become very common in the digital world and often occurs on online trading platforms. Sophisticated technology makes it easy for bashers to remain anonymous. As such, it can be difficult to track, identify, and stop bashers in their tracks.

As the internet makes participation in the stock market more accessible to more people, new investors emerging in the market are especially vulnerable to the tactics of stock bashers, and many investor boards exist to attempt to track perpetrators.

Though notoriously difficult to track, some bashers have been identified and prosecuted. From time to time, confessional essays about the tactics of bashers emerge online, although these essays are typically also either anonymous or pseudonymous. Many investors speculate this type of behavior tends to follow certain patterns, including a tendency for bashers to only bash stocks which are generally trending upwards and showing potential.

Having said that, financial regulators constantly monitor the markets for what they call bad actors or stock bashers. According to the Financial Industry Regulatory Authority (FINRA), investors may find it difficult to get information about these securities and any tidbits they may find can lead them to act even if it's misinformation. That's why FINRA warned investment firms and broker-dealers to put controls in place that would raise red flags on any suspicious activity

[lbo] 16/12/2022 12:44

Petroc has also proven himself the Med3000 tests were deficient as he posted a link to research that confirmed a lot of men with ED just spontaneously recover and need no further treatment. Especially men with Psychogenic ED and Futura started FM57 at a baseline for the study of 62% of the men needing no treatment at all!


petroc8 Dec '22 - 18:26 - 14487 of 14511

Most common reasons for the discontinuation

‘spontaneous recovery of erectile function without further treatment’





It is known that uncontrolled trials produce higher estimates of the mean effect than those obtained in a controlled trial, since by not having a control group acting as a reference, they can induce erroneous impressions about the results of the investigated drug. As they can generate a certain bias, the results of uncontrolled trials are considered less valid than those of controlled trials.



Uncontrolled Trials

This design incorporates no control arm. This design is usually utilized to determine pharmacokinetic properties of a new drug (Phase 1 trials). Uncontrolled trials are known to produce greater mean effect estimates than a controlled trial, thereby inflating the expectations from the intervention. There is a threat of inherent bias and results are considered less valid than RCT. Another issue is use of this design in spontaneously resolving maladies that might again overstate the effect

[petroc] 16/12/2022 12:28

Quick description of LiarBO and his lying, scheming, dishonest stock bashing ways -

Stock bashing has become very common in the digital world and often occurs on online trading platforms. Sophisticated technology makes it easy for bashers to remain anonymous. As such, it can be difficult to track, identify, and stop bashers in their tracks.

As the internet makes participation in the stock market more accessible to more people, new investors emerging in the market are especially vulnerable to the tactics of stock bashers, and many investor boards exist to attempt to track perpetrators.

Though notoriously difficult to track, some bashers have been identified and prosecuted. From time to time, confessional essays about the tactics of bashers emerge online, although these essays are typically also either anonymous or pseudonymous. Many investors speculate this type of behavior tends to follow certain patterns, including a tendency for bashers to only bash stocks which are generally trending upwards and showing potential.

Having said that, financial regulators constantly monitor the markets for what they call bad actors or stock bashers. According to the Financial Industry Regulatory Authority (FINRA), investors may find it difficult to get information about these securities and any tidbits they may find can lead them to act even if it's misinformation. That's why FINRA warned investment firms and broker-dealers to put controls in place that would raise red flags on any suspicious activity

[lbo] 16/12/2022 10:43

Where have the full results of FM71 or FM57 been fully published? ROFLMAO



The Journal of Andrology is the official publication of the American Society of Andrology, and is overseen and edited by Weill Cornell Medical College and The Population Council at Rockefeller University.

The new study, led by Dr. Wayne Hellstrom of Tulane University Medical Center, presents the most extensive information to date on Levitra, one of two new drugs pending FDA approval for treatment of ED. When compared to placebo, Levitra, also known by the generic name vardenafil, was shown to be effective, well-tolerated, and safe. At the highest dose, 80 percent of treated men experienced improved erections. Of men with mildly impaired erections, 89 percent returned to normal erectile function. The double-blind Phase III study involved 54 study centers and 805 patients.

[lbo] 16/12/2022 10:26

LOL

‘we have limited visibility on the potential timing and terms, given various structures and options could be considered. Importantly, current cash resources should be sufficient to reach beyond the anticipated US regulatory decision by end Q123’



The interest rate will decrease to 10% if Pro Bono Bio meets certain equity-fundraising targets.





Will Futura Medical (LON:FUM) Spend Its Cash Wisely?

That means it had a cash runway of around 13 months as of June 2022. That's not too bad, but it's fair to say the end of the cash runway is in sight

[lbo] 16/12/2022 09:58

We know how the ‘Russian gangsters as Petroc called them funded their drug free Class 2b placebo medical device gel with a loan from Knight Therspeutics! The same Knight Therapeutics linked to M8 who have a deal with Futura on the Med3000 placebo gel for Brazil! petroc 22 Nov '22 - 19:15 - 14137 of 14145Flexiseq being a Russian scam, this makes interesting reading: https://rusletter.com/articles/anatoly_chubais_spent__311_million_on_a_non-existent_ointmenthttps://www.prnewswire.com/news-releases/pro-bono-bio-launches-its-north-american-operations-and-funds-international-expansion-510072131.html

[freddievas] 16/12/2022 09:54

perhaps not. The expected tree shake in progress.

[broomrigg] 16/12/2022 09:21

This is getting repetitive!





Gainers for 14 days

EPIC Name Price Today Price Then Change Change %
FUM Futura Medical Plc 57 42.2 +14.80 35.07%



:-)

[lbo] 15/12/2022 23:07

What odds another ‘innovative deal’ for funding via a convertible loan which converts at a hefty discount is on the way for the USA like was done with China. Hedge their bets in terms of being able to continue paying all the salaries, bonuses and options even if a possible issue/delay with the De Novo medical device registration arises and the current cash runway runs out!

Market Cap is now over £160m for a company with Zero revenues and no real enforceable patent on a placebo gel that is just made of alcohol, water, glycol and Carbopol!






Death-Spiral Convertible Financier Has a Lot of Fun